2024
Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial
Zelenev A, Huedo-Medina T, Shrestha R, Mistler C, Altice F, Sibilio B, Copenhaver M. Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial. PLOS ONE 2024, 19: e0312165. PMID: 39509356, PMCID: PMC11542883, DOI: 10.1371/journal.pone.0312165.Peer-Reviewed Original ResearchConceptsHolistic Health Recovery ProgramEvidence-based interventionsHolistic healthHIV treatmentRisk behaviorsReduce HIV risk behaviorsDifference-in-differencesEnd-of-interventionControlled non-inferiority trialHIV Epidemic goalsDrug treatment settingsAttainment of viral suppressionNon-inferiority trialRecovery programViral suppressionHigh ART adherenceHIV risk behaviorsNon-inferiorityHHRP+ART adherenceBehavioral interventionsReal-world settingsNon-parametric bootstrappingCondom useOpioid-dependent people
2022
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
Haeuser E, Serfes A, Cork M, Yang M, Abbastabar H, Abhilash E, Adabi M, Adebayo O, Adekanmbi V, Adeyinka D, Afzal S, Ahinkorah B, Ahmadi K, Ahmed M, Akalu Y, Akinyemi R, Akunna C, Alahdab F, Alanezi F, Alanzi T, Alene K, Alhassan R, Alipour V, Almasi-Hashiani A, Alvis-Guzman N, Ameyaw E, Amini S, Amugsi D, Ancuceanu R, Anvari D, Appiah S, Arabloo J, Aremu O, Asemahagn M, Jafarabadi M, Awedew A, Quintanilla B, Ayanore M, Aynalem Y, Azari S, Azene Z, Darshan B, Babalola T, Baig A, Banach M, Bärnighausen T, Bell A, Bhagavathula A, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bijani A, Bitew Z, Bohlouli S, Bolarinwa O, Boloor A, Bozicevic I, Butt Z, Cárdenas R, Carvalho F, Charan J, Chattu V, Chowdhury M, Chu D, Cowden R, Dahlawi S, Damiani G, Darteh E, Darwesh A, das Neves J, Weaver N, De Leo D, De Neve J, Deribe K, Deuba K, Dharmaratne S, Dianatinasab M, Diaz D, Didarloo A, Djalalinia S, Dorostkar F, Dubljanin E, Duko B, El Tantawi M, El-Jaafary S, Eshrati B, Eskandarieh S, Eyawo O, Ezeonwumelu I, Ezzikouri S, Farzadfar F, Fattahi N, Fauk N, Fernandes E, Filip I, Fischer F, Foigt N, Foroutan M, Fukumoto T, Gad M, Gaidhane A, Gebregiorgis B, Gebremedhin K, Getacher L, Ghadiri K, Ghashghaee A, Golechha M, Gubari M, Gugnani H, Guimarães R, Haider M, Haj-Mirzaian A, Hamidi S, Hashi A, Hassanipour S, Hassankhani H, Hayat K, Herteliu C, Ho H, Holla R, Hosseini M, Hosseinzadeh M, Hwang B, Ibitoye S, Ilesanmi O, Ilic I, Ilic M, Islam R, Iwu C, Jakovljevic M, Jha R, Ji J, Johnson K, Joseph N, Joshua V, Joukar F, Jozwiak J, Kalankesh L, Kalhor R, Kamyari N, Kanchan T, Matin B, Karimi S, Kayode G, Karyani A, Keramati M, Khan E, Khan G, Khan M, Khatab K, Khubchandani J, Kim Y, Kisa A, Kisa S, Kopec J, Kosen S, Laxminarayana S, Koyanagi A, Krishan K, Defo B, Kugbey N, Kulkarni V, Kumar M, Kumar N, Kusuma D, La Vecchia C, Lal D, Landires I, Larson H, Lasrado S, Lee P, Li S, Liu X, Maleki A, Malik P, Mansournia M, Martins-Melo F, Mendoza W, Menezes R, Mengesha E, Meretoja T, Mestrovic T, Mirica A, Moazen B, Mohamad O, Mohammad Y, Mohammadian-Hafshejani A, Mohammadpourhodki R, Mohammed S, Mohammed S, Mokdad A, Moradi M, Moraga P, Mubarik S, Mulu G, Mwanri L, Nagarajan A, Naimzada M, Naveed M, Nazari J, Ndejjo R, Negoi I, Ngalesoni F, Nguefack-Tsague G, Ngunjiri J, Nguyen C, Nguyen H, Nnaji C, Noubiap J, Nuñez-Samudio V, Nwatah V, Oancea B, Odukoya O, Olagunju A, Olakunde B, Olusanya B, Olusanya J, Bali A, Onwujekwe O, Orisakwe O, Otstavnov N, Otstavnov S, Owolabi M, Mahesh P, Padubidri J, Pana A, Pandey A, Pandi-Perumal S, Kan F, Patton G, Pawar S, Peprah E, Postma M, Preotescu L, Syed Z, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi-Movaghar V, Rahmani A, Ramezanzadeh K, Rana J, Ranabhat C, Rao S, Rawaf D, Rawaf S, Rawassizadeh R, Regassa L, Rezaei N, Rezapour A, Riaz M, Ribeiro A, Ross J, Rubagotti E, Rumisha S, Rwegerera G, Moghaddam S, Sagar R, Sahiledengle B, Sahu M, Salem M, Kafil H, Samy A, Sartorius B, Sathian B, Seidu A, Shaheen A, Shaikh M, Shamsizadeh M, Shiferaw W, Shin J, Shrestha R, Singh J, Skryabin V, Skryabina A, Soltani S, Sufiyan M, Tabuchi T, Tadesse E, Taveira N, Tesfay F, Thapar R, Tovani-Palone M, Tsegaye G, Umeokonkwo C, Unnikrishnan B, Villafañe J, Violante F, Vo B, Vu G, Wado Y, Waheed Y, Wamai R, Wang Y, Ward P, Wickramasinghe N, Wilson K, Yaya S, Yip P, Yonemoto N, Yu C, Zastrozhin M, Zhang Y, Zhang Z, Hay S, Dwyer-Lindgren L. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018. BMC Medicine 2022, 20: 488. PMID: 36529768, PMCID: PMC9760541, DOI: 10.1186/s12916-022-02639-z.Peer-Reviewed Original ResearchConceptsHIV prevalenceAge groupsBackgroundHuman immunodeficiency virusJoint United Nations ProgrammeImmune deficiency syndromeHIV prevalence estimatesAdults ages 15HIV/AIDSClinic attendeesUnited Nations ProgrammeImmunodeficiency virusSentinel surveillanceDisease burdenDeficiency syndromePrevalence increasesSeroprevalence surveyPrevalence trendsLow prevalencePrevalence estimatesTreatment interventionsPrevalence differencesTargeted interventionsPrevalenceTreatment effortsAge 15Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
Collaborators G, Bryazka D, Reitsma M, Griswold M, Abate K, Abbafati C, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abdoli A, Abdollahi M, Abdullah A, Abhilash E, Abu-Gharbieh E, Acuna J, Addolorato G, Adebayo O, Adekanmbi V, Adhikari K, Adhikari S, Adnani Q, Afzal S, Agegnehu W, Aggarwal M, Ahinkorah B, Ahmad A, Ahmad S, Ahmad T, Ahmadi A, Ahmadi S, Ahmed H, Rashid T, Akunna C, Al Hamad H, Alam Z, Alem D, Alene K, Alimohamadi Y, Alizadeh A, Allel K, Alonso J, Alvand S, Alvis-Guzman N, Amare F, Ameyaw E, Amiri S, Ancuceanu R, Anderson J, Andrei C, Andrei T, Arabloo J, Arshad M, Artamonov A, Aryan Z, Asaad M, Asemahagn M, Astell-Burt T, Athari S, Atnafu D, Atorkey, Atreya A, Ausloos F, Ausloos M, Ayano G, Ayanore M, Ayinde O, Ayuso-Mateos J, Azadnajafabad S, Azanaw M, Azangou-Khyavy M, Jafari A, Azzam A, Badiye A, Bagheri N, Bagherieh S, Bairwa M, Bakkannavar S, Bakshi R, Balchut/Bilchut A, Bärnighausen T, Barra F, Barrow A, Baskaran P, Belo L, Bennett D, Benseñor I, Bhagavathula A, Bhala N, Bhalla A, Bhardwaj N, Bhardwaj P, Bhaskar S, Bhattacharyya K, Bhojaraja V, Bintoro B, Blokhina E, Bodicha B, Boloor A, Bosetti C, Braithwaite D, Brenner H, Briko N, Brunoni A, Butt Z, Cao C, Cao Y, Cárdenas R, Carvalho A, Carvalho M, Castaldelli-Maia J, Castelpietra G, Castro-de-Araujo L, Cattaruzza M, Chakraborty P, Charan J, Chattu V, Chaurasia A, Cherbuin N, Chu D, Chudal N, Chung S, Churko C, Ciobanu L, Cirillo M, Claro R, Costanzo S, Cowden R, Criqui M, Cruz-Martins N, Culbreth G, Dachew B, Dadras O, Dai X, Damiani G, Dandona L, Dandona R, Daniel B, Danielewicz A, Gela J, Davletov K, de Araujo J, de Sá-Junior A, Debela S, Dehghan A, Demetriades A, Molla M, Desai R, Desta A, da Silva D, Diaz D, Digesa L, Diress M, Dodangeh M, Dongarwar D, Dorostkar F, Dsouza H, Duko B, Duncan B, Edvardsson K, Ekholuenetale M, Elgar F, Elhadi M, Elmonem M, Endries A, Eskandarieh S, Etemadimanesh A, Fagbamigbe A, Fakhradiyev I, Farahmand F, Farinha C, Faro A, Farzadfar F, Fatehizadeh A, Fauk N, Feigin V, Feldman R, Feng X, Fentaw Z, Ferrero S, Desideri L, Filip I, Fischer F, Francis J, Franklin R, Gaal P, Gad M, Gallus S, Galvano F, Ganesan B, Garg T, Gebrehiwot M, Gebremeskel T, Gebremichael M, Gemechu T, Getacher L, Getachew M, Obsa A, Getie A, Ghaderi A, Ghafourifard M, Ghajar A, Ghamari S, Ghandour L, Nour M, Ghashghaee A, Ghozy S, Glozah F, Glushkova E, Godos J, Goel A, Goharinezhad S, Golechha M, Goleij P, Golitaleb M, Greaves F, Grivna M, Grosso G, Gudayu T, Gupta B, Gupta R, Gupta S, Gupta V, Gupta V, Hafezi-Nejad N, Haj-Mirzaian A, Hall B, Halwani R, Handiso T, Hankey G, Hariri S, Haro J, Hasaballah A, Hassanian-Moghaddam H, Hay S, Hayat K, Heidari G, Heidari M, Hendrie D, Herteliu C, Heyi D, Hezam K, Hlongwa M, Holla R, Hossain M, Hossain S, Hosseini S, hosseinzadeh M, Hostiuc M, Hostiuc S, Hu G, Huang J, Hussain S, Ibitoye S, Ilic I, Ilic M, Immurana M, Irham L, Islam M, Islam R, Islam M, Iso H, Itumalla R, Iwagami M, Jabbarinejad R, Jacob L, Jakovljevic M, Jamalpoor Z, Jamshidi E, Jayapal S, Jayarajah U, Jayawardena R, Jebai R, Jeddi S, Jema A, Jha R, Jindal H, Jonas J, Joo T, Joseph N, Joukar F, Jozwiak J, Jürisson M, Kabir A, Kabthymer R, Kamble B, Kandel H, Kanno G, Kapoor N, Karaye I, Karimi S, Kassa B, Kaur R, Kayode G, Keykhaei M, Khajuria H, Khalilov R, Khan I, Khan M, Kim H, Kim J, Kim M, Kimokoti R, Kivimäki M, Klymchuk V, Knudsen A, Kolahi A, Korshunov V, Koyanagi A, Krishan K, Krishnamoorthy Y, Kumar G, Kumar N, Kumar N, Lacey B, Lallukka T, Lasrado S, Lau J, Lee S, Lee W, Lee Y, Lim L, Lim S, Lobo S, Lopukhov P, Lorkowski S, Lozano R, Lucchetti G, Madadizadeh F, Madureira-Carvalho Á, Mahjoub S, Mahmoodpoor A, Mahumud R, Makki A, Malekpour M, Manjunatha N, Mansouri B, Mansournia M, Martinez-Raga J, Martinez-Villa F, Matzopoulos R, Maulik P, Mayeli M, McGrath J, Meena J, Nasab E, Menezes R, Mensink G, Mentis A, Meretoja A, Merga B, Mestrovic T, Jonasson J, Miazgowski B, de Sá A, Miller T, Mini G, Mirica A, Mirijello A, Mirmoeeni S, Mirrakhimov E, Misra S, Moazen B, Mobarakabadi M, Moccia M, Mohammad Y, Mohammadi E, Mohammadian-Hafshejani A, Mohammed T, Moka N, Mokdad A, Momtazmanesh S, Moradi Y, Mostafavi E, Mubarik S, Mullany E, Mulugeta B, Murillo-Zamora E, Murray C, Mwita J, Naghavi M, Naimzada M, Nangia V, Nayak B, Negoi I, Negoi R, Nejadghaderi S, Nepal S, Neupane S, Kandel S, Nigatu Y, Nowroozi A, Nuruzzaman K, Nzoputam C, Obamiro K, Ogbo F, Oguntade A, Okati-Aliabad H, Olakunde B, Oliveira G, Bali A, Omer E, Ortega-Altamirano D, Otoiu A, Otstavnov S, Oumer B, Mahesh P, Padron-Monedero A, Palladino R, Pana A, Panda-Jonas S, Pandey A, Pandey A, Pardhan S, Parekh T, Park E, Parry C, Kan F, Patel J, Pati S, Patton G, Paudel U, Pawar S, Peden A, Petcu I, Phillips M, Pinheiro M, Plotnikov E, Pradhan P, Prashant A, Quan J, Radfar A, Rafiei A, Raghav P, Rahimi-Movaghar V, Rahman A, Rahman M, Rahman M, Rahmani A, Rahmani S, Ranabhat C, Ranasinghe P, Rao C, Rasali D, Rashidi M, Ratan Z, Rawaf D, Rawaf S, Rawal L, Renzaho A, Rezaei N, Rezaei S, Rezaeian M, Riahi S, Romero-Rodríguez E, Roth G, Rwegerera G, Saddik B, Sadeghi E, Sadeghian R, Saeed U, Saeedi F, Sagar R, Sahebkar A, Sahoo H, Sahraian M, Saif-Ur-Rahman K, Salahi S, Salimzadeh H, Samy A, Sanmarchi F, Santric-Milicevic M, Sarikhani Y, Sathian B, Saya G, Sayyah M, Schmidt M, Schutte A, Schwarzinger M, Schwebel D, Seidu A, Kumar N, SeyedAlinaghi S, Seylani A, Sha F, Shahin S, Shahraki-Sanavi F, Shahrokhi S, Shaikh M, Shaker E, Shakhmardanov M, Shams-Beyranvand M, Sheikhbahaei S, Sheikhi R, Shetty A, Shetty J, Shiferaw D, Shigematsu M, Shiri R, Shirkoohi R, Shivakumar K, Shivarov V, Shobeiri P, Shrestha R, Sidemo N, Sigfusdottir I, Silva D, da Silva N, Singh J, Singh S, Skryabin V, Skryabina A, Sleet D, Solmi M, SOLOMON Y, Song S, Song Y, Sorensen R, Soshnikov S, Soyiri I, Stein D, Subba S, Szócska M, Tabarés-Seisdedos R, Tabuchi T, Taheri M, Tan K, Tareke M, Tarkang E, Temesgen G, Temesgen W, Temsah M, Thankappan K, Thapar R, Thomas N, Tiruneh C, Todorovic J, Torrado M, Touvier M, Tovani-Palone M, Tran M, Trias-Llimós S, Tripathy J, Vakilian A, Valizadeh R, Varmaghani M, Varthya S, Vasankari T, Vos T, Wagaye B, Waheed Y, Walde M, Wang C, Wang Y, Wang Y, Westerman R, Wickramasinghe N, Wubetu A, Xu S, Yamagishi K, Yang L, Yesera G, Yigit A, Yiğit V, Yimaw A, Yon D, Yonemoto N, Yu C, Zadey S, Zahir M, Zare I, Zastrozhin M, Zastrozhina A, Zhang Z, Zhong C, Zmaili M, Zuniga Y, Gakidou E. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet 2022, 400: 185-235. PMID: 35843246, PMCID: PMC9289789, DOI: 10.1016/s0140-6736(22)00847-9.Peer-Reviewed Original ResearchConceptsTheoretical minimum risk exposure levelStandard drinksAlcohol consumptionGlobal burdenHealth outcomesDisease ratesModerate alcohol consumptionRelative risk curveHealth risksPopulation-level riskAge groupsRisk curvesOverall riskRisk exposure levelAlcohol useHarmful amountsMelinda Gates FoundationHealth lossYoung individualsExposure levelsAgeRiskSexDrinksDaysClinical and Demographic Differences in the Willingness to use Self-Administered At-Home COVID-19 Testing Measures among Persons with Opioid use Disorder
Mistler CB, Sullivan M, Wickersham JA, Copenhaver MM, Shrestha R. Clinical and Demographic Differences in the Willingness to use Self-Administered At-Home COVID-19 Testing Measures among Persons with Opioid use Disorder. Substance Use & Addiction Journal 2022, 43: 708-712. PMID: 35100084, PMCID: PMC9725184, DOI: 10.1080/08897077.2021.2007511.Peer-Reviewed Original ResearchMeSH KeywordsAgedCOVID-19COVID-19 TestingEthnicityFemaleHumansMiddle AgedOpioid-Related DisordersSARS-CoV-2ConceptsOpioid use disorderCOVID-19 testPrick testUse disordersCOVID-19Older aged participantsTesting measuresSaliva-based testThroat swab samplesCOVID-19 transmissionGreater proportionGreater riskSwab samplesAdverse effectsAged participantsTesting optionsDisadvantaged populationsRacial-ethnic minoritiesWhite participantsDemographic differencesDisordersHome ordersGreater rateTreatmentParticipants
2021
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
Collaborators G, Kendrick P, Reitsma M, Abbasi-Kangevari M, Abdoli A, Abdollahi M, Abedi A, Abhilash E, Aboyans V, Adebayo O, Advani S, Ahinkorah B, Ahmad S, Ahmadi K, Ahmed H, Aji B, Akalu Y, Akunna C, Alahdab F, Al-Aly Z, Alanezi F, Alanzi T, Alhabib K, Ali T, Alif M, Alipour V, Aljunid S, Alomari M, Amin T, Amini S, Amu H, Ancuceanu R, Anderson J, Andrei C, Andrei T, Ansari-Moghaddam A, Antony B, Anvari D, Arabloo J, Arian N, Arora M, Artanti K, Asmare W, Atnafu D, Ausloos M, Awan A, Ayano G, Aynalem G, Azari S, Darshan B, Badiye A, Baig A, Banach M, Banerjee S, Barker-Collo S, Bärnighausen T, Barqawi H, Basu S, Bayati M, Bazargan-Hejazi S, Bekuma T, Bennett D, Bensenor I, Benzian H, Benziger C, Berman A, Bhagavathula A, Bhala N, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bibi S, Bijani A, Biondi A, Braithwaite D, Brenner H, Brunoni A, Burkart K, Nagaraja S, Butt Z, dos Santos F, Car J, Carreras G, Castaldelli-Maia J, Cattaruzza M, Chang J, Chaturvedi P, Chen S, Chido-Amajuoyi O, Chu D, Chung S, Ciobanu L, Costa V, Couto R, Dagnew B, Dai X, Damasceno A, Damiani G, Dandona L, Dandona R, Daneshpajouhnejad P, Gela J, Molla M, Desta A, Dharmaratne S, Dhimal M, Eagan A, Kalan M, Edvardsson K, Effiong A, Tantawi M, Elbarazi I, Esmaeilnejad S, Fadhil I, Faraon E, Farwati M, Farzadfar F, Fazlzadeh M, Feigin V, Feldman R, Filip I, Filippidis F, Fischer F, Flor L, Foigt N, Folayan M, Foroutan M, Gad M, Gallus S, Geberemariyam B, Gebregiorgis B, Getacher L, Obsa A, Ghafourifard M, Gheshlagh R, Ghashghaee A, Ghith N, Gil G, Gill P, Ginawi I, Goharinezhad S, Golechha M, Gopalani S, Gorini G, Grivna M, Guha A, Guimarães R, Guo Y, Gupta R, Gupta R, Gupta T, Gupta V, Hafezi-Nejad N, Haider M, Hamadeh R, Hankey G, Hargono A, Hay S, Heidari G, Herteliu C, Hezam K, Hird T, Holla R, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hsiao T, Huang J, Ibeneme C, Ibitoye S, Ilic I, Ilic M, Inbaraj L, Irvani S, Islam J, Islam R, Islam M, Islami F, Iso H, Itumalla R, Jaafari J, Jain V, Jakovljevic M, Jang S, Jayaram S, Jeemon P, Jha R, Jonas J, Jürisson M, Kabir A, Kabir Z, Kalankesh L, Kanchan T, Kandel H, Kapoor N, Karch A, Karimi S, Kebede K, Kelkay B, Kennedy R, Khader Y, Khan E, Khayamzadeh M, Kim G, Kimokoti R, Kivimäki M, Kosen S, Laxminarayana S, Koyanagi A, Krishan K, Kugbey N, Kumar G, Kumar N, Kurmi O, Kusuma D, Lacey B, Landires I, Lasrado S, Lauriola P, Lee D, Lee Y, Leung J, Li S, Lin H, Liu W, Lugo A, Kunjathur S, Majeed A, Maleki A, Malekzadeh R, Malta D, Mamun A, Manjunatha N, Mansouri B, Mansournia M, Martini S, Mathur M, Mathur P, Mazidi M, McKee M, Medina-Solís C, Mehata S, Mendoza W, Menezes R, Miazgowski B, Michalek I, Miller T, Mini G, Mirica A, Mirrakhimov E, Mirzaei H, Misra S, Mohammad Y, Mohammadian-Hafshejani A, Mohammed S, Mokdad A, Molokhia M, Monasta L, Moni M, Moradzadeh R, Morrison S, Mossie T, Mubarik S, Mullany E, Murray C, Nagaraju S, Naghavi M, Naik N, Nalini, Nangia V, Naqvi A, Swamy S, Naveed M, Nazari J, Nduaguba S, Negoi R, Kandel S, Nguyen H, Nigatu Y, Nixon M, Nnaji C, Noubiap J, Nowak C, Nuñez-Samudio V, Ogbo F, Oguntade A, Oh I, Olagunju A, Owolabi M, Mahesh P, Pakshir K, Pana A, Panagiotakos D, Panda-Jonas S, Pandey A, Parekh U, Park E, Park E, Kan F, Pathak M, Pawar S, Pestell R, Pham H, Pinheiro M, Pokhrel K, Pourshams A, Prashant A, Radfar A, Rahimi-Movaghar V, Rahman M, Rahman M, Rahmani A, Ram P, Rana J, Ranabhat C, Rathi P, Rawaf D, Rawaf S, Rawassizadeh R, Renzaho A, Rezapour A, Riaz M, Roever L, Ronfani L, Roshandel G, Roy A, Roy B, Saddik B, Sahebkar A, Salehi S, Salimzadeh H, Samy A, Sanabria J, Santric-Milicevic M, Jose B, Sathian B, Sawhney M, Saya G, Schwendicke F, Seidu A, Kumar N, Sepanlou S, Shafaat O, Shah S, Shaikh M, Shannawaz M, Sharafi K, Sheikh A, Sheikhbahaei S, Shigematsu M, Shiri R, Shishani K, Shivakumar K, Shivalli S, Shrestha R, Siabani S, Sidemo N, Sigfusdottir I, Sigurvinsdottir R, Silva J, Singh A, Singh J, Singh V, Sinha D, Skryabin V, Skryabina A, Soroush A, Soyiri I, Sreeramareddy C, Stein D, Steiropoulos P, Stortecky S, Straif K, Abdulkader R, Sulo G, Sundström J, Tabuchi T, Tadesse E, Tamiru A, Tareke M, Tareque I, Tarigan I, Thakur B, Thankappan K, Thapar R, Tolani M, Tovani-Palone M, Tran B, Tripathy J, Tsegaye G, Tymeson H, Ullah S, Unim B, Updike R, Uthman O, Vacante M, Vardavas C, Venketasubramanian N, Verma M, Vidale S, Vo B, Vu G, Waheed Y, Wang Y, Welding K, Werdecker A, Whisnant J, Wickramasinghe N, Wubishet B, Yamagishi K, Yano Y, Yazdi-Feyzabadi V, Yeshaw Y, Yimmer M, Yonemoto N, Yousefi Z, Yu C, Yunusa I, Yusefzadeh H, Zaman M, Zamani M, Zamanian M, Zastrozhin M, Zastrozhina A, Zhang J, Zhang Z, Zhong C, Zuniga Y, Gakidou E. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Public Health 2021, 6: e482-e499. PMID: 34051920, PMCID: PMC8251505, DOI: 10.1016/s2468-2667(21)00065-7.Peer-Reviewed Original ResearchConceptsGlobal age-standardised prevalenceAge-standardised prevalenceTobacco useSignificant decreaseGlobal burdenRisk Factors Study (GBD) 2019Substantial public health problemDisease Study 2019High prevalence countriesAdverse health outcomesPublic health problemSmokeless tobacco useSmokeless tobacco productsGlobal health communitySmoking tobaccoPrevalence countriesSmoking useHigh prevalenceTobacco usersWHO Framework ConventionHealth outcomesHealth problemsPrevalenceSame time periodTobacco productsDeveloping a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment
Copenhaver MM, Sanborn V, Shrestha R, Mistler CB, Sullivan MC, Gunstad J. Developing a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment. Drug And Alcohol Dependence 2021, 224: 108726. PMID: 33930640, PMCID: PMC8180490, DOI: 10.1016/j.drugalcdep.2021.108726.Peer-Reviewed Original ResearchConceptsMild cognitive impairmentCognitive dysfunctionRisk scoreDrug treatmentPredictors of MCIOpioid-dependent personsOpioid use disorderPredictive risk scoreMedical chart dataNeuro-cognitive impairmentResource-limited settingsChart dataDrug treatment facilitiesAddiction-related servicesLarger validation studiesPatient demographicsROC curve areaUse disordersTreatment engagementCognitive impairmentPatientsOptimal cutClinical settingLogistic regressionMCI casesThe Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals
Mistler CB, Curley CM, Rosen AO, El-Krab R, Wickersham JA, Copenhaver MM, Khati A, Shrestha R. The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals. Journal Of Community Health 2021, 46: 960-966. PMID: 33770334, PMCID: PMC7996112, DOI: 10.1007/s10900-021-00979-0.Peer-Reviewed Original ResearchConceptsOpioid use disorderHIV prevention servicesSTI testingHIV counselorsPrEP prescriptionPrevention servicesCOVID-19Pre-exposure prophylaxis servicesOpioid use disorder treatmentCOVID-19 pandemicClean injection equipmentOpioid-dependent individualsOpioid-dependent peopleUse disorder treatmentInjection equipmentHIV testingInfection testingBlood testingHIV preventionUse disordersPWIDDisorder treatmentDoctor's appointmentAdverse effectsCase managers
2020
Response to the COVID-19 Outbreak in Urban Settings in China
Ni Z, Lebowitz ER, Zou Z, Wang H, Liu H, Shrestha R, Zhang Q, Hu J, Yang S, Xu L, Wu J, Altice FL. Response to the COVID-19 Outbreak in Urban Settings in China. Journal Of Urban Health 2020, 98: 41-52. PMID: 33258088, PMCID: PMC7703725, DOI: 10.1007/s11524-020-00498-8.Peer-Reviewed Original ResearchAssociation between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment
Copenhaver MM, Sanborn V, Shrestha R, Mistler C, Gunstad J. Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment. Journal Of Addictive Diseases 2020, 39: 166-174. PMID: 33047651, PMCID: PMC11395862, DOI: 10.1080/10550887.2020.1831129.Peer-Reviewed Original ResearchConceptsMethadone maintenance therapyDrug treatmentNeurocognitive dysfunctionNeurocognitive impairmentOpioid use disorderPossible clinical utilityAccommodation of patientsNIH ToolboxSubjective cognitive dysfunctionMaintenance therapyObjective cognitive testingSpecific neurocognitive profileTreatment outcomesCognitive dysfunctionClinical utilityUse disordersBrief inventoryObjective test performanceDysfunctionCognitive testingCutoff scoreNeurocognitive profileTest batteryObjective performanceImpairment
2019
HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients
Shrestha R, Altice FL, Copenhaver MM. HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2019, 80: 166-173. PMID: 30383588, PMCID: PMC6331231, DOI: 10.1097/qai.0000000000001891.Peer-Reviewed Original ResearchConceptsOptimal ART adherenceAntiretroviral therapyMethadone-maintained patientsMethadone maintenance treatmentART adherenceMaintenance treatmentHIV treatment outcomesHIV-positive patientsOpioid agonist therapyMultivariable logistic regressionHIV risk behaviorsExplanatory pathwaysAgonist therapySuboptimal adherenceMedication adherenceHIV treatmentTreatment outcomesHIV stigmaPatientsLogistic regressionHIVPrevention initiativesTherapyAdherenceSignificant correlates
2018
Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART)
Shrestha R, Copenhaver MM. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART). Addictive Behaviors 2018, 85: 88-93. PMID: 29879611, PMCID: PMC6337064, DOI: 10.1016/j.addbeh.2018.05.031.Peer-Reviewed Original ResearchConceptsMethadone maintenance therapyMethadone-maintained patientsOngoing injection drug useViral suppressionAntiretroviral therapyInjection drug useHIV risk behaviorsDrug useSelf-reported HIV risk behaviorsImproved virologic outcomesOptimal ART adherenceHigher CD4 countsSustained viral suppressionMultivariable logistic regressionVirologic outcomesCD4 countMaintenance therapyOptimal adherenceART adherenceHIV treatmentIndependent correlatesTreatment challengesRisk populationsPatientsHIVIntegrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study
Shrestha R, Altice FL, Karki P, Copenhaver MM. Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study. AIDS And Behavior 2018, 22: 2640-2649. PMID: 29582199, PMCID: PMC6051885, DOI: 10.1007/s10461-018-2099-0.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalgesics, OpioidBiobehavioral SciencesCondomsFeasibility StudiesFemaleHIV InfectionsHumansMaleMedication AdherenceMethadoneMiddle AgedMotivationOpiate Substitution TreatmentOpioid-Related DisordersPatient Acceptance of Health CarePilot ProjectsPre-Exposure ProphylaxisProspective StudiesRisk Reduction BehaviorSexual BehaviorSexual PartnersSubstance Abuse, IntravenousConceptsPre-exposure prophylaxis adherenceSelf-reported PrEP adherenceSex-related risk behaviorsHIV risk reduction behaviorsBio-behavioral interventionPre-exposure prophylaxisProspective clinical trialsHigh-risk peopleHIV prevention interventionsHIV risk behaviorsPilot feasibility studyPost-intervention assessmentPrEP adherenceProphylaxis adherencePreliminary efficacyClinical trialsIntervention groupHIV riskPrevention interventionsRisk behaviorsBio-behavioral approachAdherenceInterventionHigh acceptabilityPrEP
2017
Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users
Shrestha R, Karki P, Altice FL, Dubov O, Fraenkel L, Huedo-Medina T, Copenhaver M. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users. AIDS And Behavior 2017, 22: 1228-1238. PMID: 28695388, PMCID: PMC5762432, DOI: 10.1007/s10461-017-1851-1.Peer-Reviewed Original ResearchConceptsPre-exposure prophylaxisSex-related risk behaviorsHigh-risk drug usersAcceptability of PrEPHigh-risk PWUDPrimary HIV preventionHIV prevention approachesDrug treatment settingsKey risk populationsHIV-negative PWUDHigh acceptabilityHIV clinicPrEP acceptabilityHIV testingPrEP uptakeMethadone clinicsHIV preventionRisk populationsSide effectsTreatment settingsDrug usersPrEP attributesRisk behaviorsPrEPUnderserved populationsIntent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis
Shrestha R, Karki P, Huedo-Medina TB, Copenhaver M. Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis. Journal Of The Association Of Nurses In AIDS Care 2017, 28: 612-621. PMID: 28478870, PMCID: PMC7451137, DOI: 10.1016/j.jana.2017.04.005.Peer-Reviewed Original ResearchConceptsHIV risk behaviorsNeurocognitive impairmentRisk behaviorsPreexposure prophylaxisSelf-reported neurocognitive symptomsHigh-risk drug usersHigh-risk PWUDPrEP uptakeNeurocognitive symptomsHIV riskDrug usersSimilar outcomesUnderserved populationsSignificant correlatesProphylaxisImportant unanswered questionsPreliminary evidencePrEPDissemination effortsMediation analysisUnanswered questionsVariables of interestHIVSymptomsCliniciansCorrelates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment
Shrestha R, Karki P, Altice FL, Huedo-Medina TB, Meyer JP, Madden L, Copenhaver M. Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. Drug And Alcohol Dependence 2017, 173: 107-116. PMID: 28214391, PMCID: PMC5366273, DOI: 10.1016/j.drugalcdep.2016.12.023.Peer-Reviewed Original ResearchConceptsPre-exposure prophylaxisHIV risk reductionDrug injectionHIV riskRisk behaviorsHigh-risk drug usersHigh-risk PWUDOpioid-dependent personsHIV prevention approachesRecent risk behaviorsCross-sectional studyConsistent condom useHigh-risk behaviorsRisk reductionCorrelates of willingnessPrEP deliveryMethadone treatmentIndependent correlatesMethadone programsSafe drugElevated riskCasual partnersNeurocognitive impairmentDrug usersKey populationsA Moderated Mediation Model of HIV-Related Stigma, Depression, and Social Support on Health-Related Quality of Life among Incarcerated Malaysian Men with HIV and Opioid Dependence
Shrestha R, Copenhaver M, Bazazi AR, Huedo-Medina TB, Krishnan A, Altice FL. A Moderated Mediation Model of HIV-Related Stigma, Depression, and Social Support on Health-Related Quality of Life among Incarcerated Malaysian Men with HIV and Opioid Dependence. AIDS And Behavior 2017, 21: 1059-1069. PMID: 28108877, PMCID: PMC5344717, DOI: 10.1007/s10461-017-1693-x.Peer-Reviewed Original Research
2016
Willingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment
Shrestha R, Altice FL, Huedo-Medina TB, Karki P, Copenhaver M. Willingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment. AIDS And Behavior 2016, 21: 1299-1308. PMID: 27990587, PMCID: PMC5380590, DOI: 10.1007/s10461-016-1650-0.Peer-Reviewed Original ResearchConceptsHigh-risk PWUDBehavioral skills modelCommunity-based methadone maintenance treatmentPre-exposure prophylaxis trialsSex-related HIV risk behaviorsHigh-risk drug usersPre-exposure prophylaxisIMB modelMethadone maintenance treatmentEfficacy of PrEPUse of PrEPHIV risk behaviorsKey risk populationsHealth behavior changeHIV acquisitionProphylaxis trialsHIV infectionMaintenance treatmentHIV preventionRisk populationsDrug usersRisk behaviorsPrEPPWUDIntervention developmentTreatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment
Shrestha R, Karki P, Huedo-Medina TB, Copenhaver M. Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment. Journal Of The Association Of Nurses In AIDS Care 2016, 28: 85-94. PMID: 27769735, PMCID: PMC5183513, DOI: 10.1016/j.jana.2016.09.007.Peer-Reviewed Original ResearchThe Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis
Shrestha R, Weikum D, Copenhaver M, Altice FL. The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis. AIDS And Behavior 2016, 21: 1070-1081. PMID: 27544515, PMCID: PMC5318281, DOI: 10.1007/s10461-016-1526-3.Peer-Reviewed Original ResearchConceptsAlcohol use disorderNeurocognitive impairmentUse disordersMalaysia's largest prisonHealth-related qualityNeuropsychological factorsQuality of lifeLargest prisonHIV-InfectedOpioid dependenceHIV treatmentHRQoLImportant negative predictorMeeting criteriaFuture interventionsDepressionNegative predictorPLWHDisordersMalaysian menStandardized scalesImpairmentMediation analysisHRQoL.HIVAssociation Between Intimate Partner Violence Against Women and HIV-Risk Behaviors
Shrestha R, Copenhaver MM. Association Between Intimate Partner Violence Against Women and HIV-Risk Behaviors. Violence Against Women 2016, 22: 1621-1641. PMID: 26912296, PMCID: PMC5308057, DOI: 10.1177/1077801216628690.Peer-Reviewed Original ResearchConceptsHIV risk behaviorsIntimate partner violenceSignificant global health issueInconsistent condom useAdverse health outcomesSTIs/HIVMultiple sex partnersSafer sexual practicesGlobal health issueHIV infectionHIV riskPartner violenceHealth outcomesSex partnersCondom useDisproportionate burdenEffective interventionsHealth issuesWomenHIVSexual practicesInfectionPotential relationshipRisk